Author:
Guckel Denise,Sohns Christian
Publisher
Deutscher Arzte-Verlag GmbH
Reference41 articles.
1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL: ESC Scientific Document Group: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 1 February 2021; 42 (5): 373–498; DOI: 10.1093/eurheartj/ehaa612.
2. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al.: American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 2019; 139: e56-e528; DOI: 10.1161/CIR.0000000000000659.
3. Costard-Jäckle A, Tschöpe D, Meinertz T: Cardiovascular outcome in type 2 diabetes and atrial fibrillation. Herz 2019; 44: 522–5; DOI: 10.1007/s00059–018–4704–4.
4. Stegmann C, Jahnke C, Paetsch I, Hilbert S, Arya A, Bollmann A, et al.: Association of left ventricular late gadolinium enhancement with left atrial low voltage areas in patients with atrial fibrillation. Europace 2018; 20: 1606–11; DOI: 10.1093/europace/euy013.
5. Huxley RR, Filion KB, Konety S, Alonso A: Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 1 July 2011; 108 (1): 56–62; DOI: 10.1016/j.amjcard.2011.03.004.